← Back to feed
Vanguard Business·June 30, 2026 at 6:53 AM

Shareholders of Neimeth International Pharmaceuticals Plc have approved the Board of Directors' plans to raise additional capital aimed at accelerating the company's expansion and completing its pharmaceutical manufacturing facility in Amawbia, Anambra State. This decision was made during the company's 67th Annual General Meeting (AGM), which was held virtually, where shareholders unanimously approved all resolutions proposed by the board.

AI summary. Verify with the original source.

Neimethshareholdersexpansionpharmaceuticals

Read full story at Vanguard Business

Listen

Audio summaries is a Premium feature

Unlock audio summaries, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Background facts

Wikipedia facts is a Premium feature

Unlock wikipedia facts, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Similar stories